Keywords: Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non-Gas), Hepatocellular Carcinoma, Kinetic Modeling
Motivation: While hyperpolarized 1-13C Pyruvate Magnetic Resonance Spectroscopy holds great promise for in vivo profiling of cellular metabolism, the molecular alterations underlying the observed metabolic phenotypes (metabotypes) remain understudied.
Goal(s): We sought to characterize the molecular features contributing to the metabotypes identified on Hyperpolarized 1-13C Pyruvate MRS in hepatocellular carcinoma (HCC).
Approach: We integrated transcriptomic and proteomic profiling together with hyperpolarized 1-13C Pyruvate MRS of HCC patient-derived xenografts (PDX) that recapitulate the diversity of gene and protein expression observed in patients.
Results: Our data suggest that hyperpolarized 1-13C Pyruvate MRS distinguishes HCC metabotypes based on MCT4 expression.
Impact: By applying clinically relevant PDX models of HCC harboring naturally occurring variability in expression of metabolic enzymes and transporters, our data provide critical insights into the interpretation of hyperpolarized 1-13C Pyruvate MRS during clinical translation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords